<SEC-DOCUMENT>0001125345-22-000014.txt : 20220224
<SEC-HEADER>0001125345-22-000014.hdr.sgml : 20220224
<ACCEPTANCE-DATETIME>20220224160714
ACCESSION NUMBER:		0001125345-22-000014
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220224
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220224
DATE AS OF CHANGE:		20220224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		22670948

	BUSINESS ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mgnx-20220224.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:312ed510-66ae-416f-90ea-006795df12a1,g:01123119-117e-440f-aa80-e8f2b88ebc12,d:474f453f305e44cb9ebb41722fd92f94--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20220224</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF80L2ZyYWc6OTY0Zjg3MmE2ZjQxNDU4NWE1MmRjYzVjM2M1NDg1MDUvdGFibGU6OWQ3ZTBlMTEzYTg2NGVkZGE1YWIwZDk4ZTYzNTNjMjQvdGFibGVyYW5nZTo5ZDdlMGUxMTNhODY0ZWRkYTVhYjBkOThlNjM1M2MyNF8yLTEtMS0xLTE3ODY3_2fb93857-3d17-4dc1-8982-93cb5491272f">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF80L2ZyYWc6OTY0Zjg3MmE2ZjQxNDU4NWE1MmRjYzVjM2M1NDg1MDUvdGFibGU6OWQ3ZTBlMTEzYTg2NGVkZGE1YWIwZDk4ZTYzNTNjMjQvdGFibGVyYW5nZTo5ZDdlMGUxMTNhODY0ZWRkYTVhYjBkOThlNjM1M2MyNF8zLTEtMS0xLTE3ODY3_d39e0811-40c7-42d0-8d53-759f3f61eeb0">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20220224.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-24</xbrli:startDate><xbrli:endDate>2022-02-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i474f453f305e44cb9ebb41722fd92f94_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xMDY_0742c4da-8bbf-4f9f-8591-348208c39ef3">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8yNTI_c64596b8-8480-4897-b459-fc6af6d27962">February&#160;24, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8yNTc_ed898f18-43e1-438e-bcbd-138868efcd4e">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTAtMS0xLTE3ODY3_92e56f87-5ebb-4a13-a937-0bf69d22e8e8">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTEtMS0xLTE3ODY3_04ef72d8-cb3b-459e-9267-f756ec853ed1">001-36112</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTItMS0xLTE3ODY3_100b7ffe-8dfa-4a53-9f08-a807de025932">06-1591613</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:23.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt;padding-right:24.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8wLTAtMS0yLTE3ODY3_6569468f-6fe3-49ca-91a6-de49ea1b0942">9704 Medical Center Drive</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTAtMS0xLTE3ODY3_69cf3da9-2b91-4ae6-bd09-75f295b69fb4">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTEtMS0xLTE3ODY3_76e234c7-d143-43ce-bf79-a2877fbbb25d">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTMtMS0xLTE3ODY3_a25cddf8-6e94-47b6-a5dc-a1f9864a2723">20850</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8zNzM_489496a0-0015-46a4-9f7b-16935a6c1475">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8zNzc_66e58a17-08ea-4d50-ab14-536166fb70e2">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.051%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTAtMS0xLTE3ODY3_deced0b7-3e7f-4925-b122-770fd41353ba">Common Stock, par value $0.01 per share</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTEtMS0xLTE3ODY3_86dbd62c-5e10-4e5e-8712-9453a88cc32a">MGNX</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTItMS0xLTE3ODY3_0264b100-390b-4b54-a3d0-17cedcf98321">Nasdaq Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQy_85ee0616-207a-4172-914a-a5b64de91679">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQz_261ba07e-65c0-419a-814c-90c2efec67e4">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ0_9eecf223-6f34-49d0-bb5d-73444b02b683">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ1_1690f839-b3b6-4be8-b0c8-2ce4a64775f6">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ2_55b17fcc-d3c4-4219-8c86-98acc3a97319">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i474f453f305e44cb9ebb41722fd92f94_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;24, 2022,  MacroGenics, Inc. (the "Company") announced financial and operating results as of and for the year ended December&#160;31, 2021. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information provided under this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:15.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(d) Exhibits.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:15.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1earningspressre.htm">99.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1earningspressre.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1earningspressre.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1earningspressre.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1earningspressre.htm">bruary 24, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:48.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 24, 2022</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1earningspressre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5d590c8f7f474939b87d9612781b16d4_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 99.1</font></div></div><div><img alt="macrogenics20logo_jpgormat.jpg" src="macrogenics20logo_jpgormat.jpg" style="height:88px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="padding-right:-6.75pt;text-align:center"><font><br></font></div><div style="padding-right:-6.75pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:115%">MacroGenics Provides Update on Corporate Progress and 2021 Financial Results</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#58585a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:135%">&#8226;</font><font style="color:#58585a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:135%;padding-left:12.03pt">Initiating Phase 1 dose escalation study of MGC018 in combination with lorigerlimab (formerly MGD019) in coming weeks</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:135%">&#8226;</font><font style="color:#58585a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:135%;padding-left:12.03pt">Prioritizing MGD024 as lead CD3-based DART&#174; molecule targeting CD123 and discontinuing development of flotetuzumab</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:135%">&#8226;</font><font style="color:#58585a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:135%;padding-left:12.03pt">Presented encouraging preclinical combinatorial anti-tumor activity with MGD024 at ASH in December</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:135%">&#8226;</font><font style="color:#58585a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:135%;padding-left:12.03pt">Conference call scheduled for today at&#8239;4&#58;30 p.m. ET. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROCKVILLE, MD., February&#160;24, 2022 (GLOBE NEWSWIRE)</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> --MacroGenics, Inc. (NASDAQ&#58; MGNX), a biopharmaceutical company focused on developing and commercializing innovative  antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December&#160;31, 2021</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are excited about our 2022 plans for our B7-H3-directed programs for the potential treatment of multiple solid tumors. We believe we are well-positioned to be a leader in this promising field and are prioritizing our efforts around B7-H3. First, I am pleased to share that later this quarter, we plan to meet with the U.S. Food and Drug Administration (FDA) to discuss the design of a potential registration-directed study of MGC018 in patients with metastatic castration-resistant prostate cancer (mCRPC).</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Second, we expect to initiate a study of MGC018 in combination with lorigerlimab, our bispecific DART molecule targeting PD-1 and CTLA-4, in the coming weeks. And third, during the second half of this year, we intend to provide an update from a study of our second B7-H3 targeted molecule, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">en</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">oblituzumab, being evaluated in combination with two of our checkpoint molecules in front-line </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">squamous cell carcinoma of the head and neck (SCCHN)</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Beyond these B7-H3 programs, we are advancing several of our other clinical-stage molecules and have a variety of ongoing preclinical activities intended to expand our pipeline of differentiated investigational product candidates for the potential treatment of cancer,&#8221; said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Updates on Proprietary Programs </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B7-H3 Programs&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MacroGenics is developing two investigational, clinical product candidates that target B7-H3, an antigen with broad expression across multiple solid tumor types and a member of the B7 family of molecules involved in immune regulation. Recent highlights for these two molecules include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt">MGC018</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is an antibody-drug conjugate (ADC) that targets B7-H3. MacroGenics presented encouraging preliminary clinical results from an ongoing Phase 1&#47;2 study of MGC018 in patients with solid tumors at the American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) meetings in 2021. The Phase </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1&#47;2 study expansion cohorts are fully enrolled for patients with mCRPC (n&#61;40) and smaller cohorts of patients (n&#61;approximately 20 each) with non-small cell lung cancer (NSCLC), melanoma and triple negative breast cancer (TNBC), while the Company continues to recruit patients for the SCCHN cohort. MacroGenics plans to meet with FDA later this quarter to discuss its development strategy in mCRPC. In addition, the Company intends to provide an update on clinical data from the dose expansion cohorts in the second half of 2022 as the data further mature. Finally, beyond monotherapy, the Company expects to initiate a combination study of MGC018 with lorigerlimab across multiple indications in the coming weeks.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt">Enoblituzumab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is an Fc&#8208;engineered, monoclonal antibody (mAb) that targets B7&#8208;H3. MacroGenics continues to recruit patients into its Phase 2 study of enoblituzumab in combination with retifanlimab, the Company's investigational, anti-PD-1 antibody that was licensed to Incyte, in front-line patients with SCCHN who are PD-L1 positive and with tebotelimab in SCCHN patients who are PD-L1 negative. The Company expects to complete enrollment of the PD-L1 positive patient cohort during the first half of this year and provide an update on this cohort during the second half of the year. I-Mab, MacroGenics&#8217; partner in Greater China, announced in December that the Center for Drug Evaluation (CDE) of China&#8217;s National Medical Products Administration (NMPA) approved its Investigational New Drug (IND) submission for the initiation of a Phase 2 trial in China for enoblituzumab in combination with pembrolizumab in patients with solid tumors, including NSCLC, urothelial carcinoma and other selected cancers. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DART Molecules for Immune Checkpoint Blockade&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MacroGenics is studying multiple investigational, PD-1-directed programs to provide further differentiation from existing PD-1-based treatment options and enable combination opportunities across the Company&#8217;s portfolio. Recent highlights include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt"> Lorigerlimab (formerly MGD019)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a bispecific, tetravalent DART molecule targeting PD-1 and CTLA-4. MacroGenics is conducting a Phase 1&#47;2 dose expansion study in cohorts of patients with microsatellite stable colorectal cancer (MSS CRC), mCRPC, melanoma and checkpoint-na&#239;ve NSCLC. The Company anticipates sharing data from this ongoing study in the second half of 2022. As described above, MacroGenics expects to initiate a dose escalation study of MGC018 in combination with lorigerlimab in the coming weeks. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">Tebotelimab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8239;is a bispecific, tetravalent DART molecule targeting PD-1 and LAG-3. Tebotelimab was evaluated in a Phase 1&#47;2 dose expansion study in several tumor types and is currently being studied in combination with enoblituzumab in SCCHN. The Company expects to provide an update on potential future development plans for tebotelimab in the second half of 2022. MacroGenics' partner in Greater China, Zai lab, recently informed the Company that it has decided to discontinue development of tebotelimab for indications it was enrolling in its territory and is evaluating future development plans in other indications.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bispecific CD123 &#215; CD3 DART molecule</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; MacroGenics has prioritized the development of MGD024, its investigational, next-generation CD123 &#215; CD3 DART molecule, and will discontinue the development of flotetuzumab. Recent updates of these DART molecules include&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt">MGD024</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a next-generation, humanized CD123 &#215; CD3 DART molecule designed to minimize cytokine-release syndrome, while maintaining anti-tumor cytolytic activity, and permitting intermittent dosing through a longer half-life. In November, MacroGenics announced submission of an IND application for MGD024 to FDA.  At the American Society of Hematology (ASH) Annual Meeting in December, MacroGenics presented preclinical data from the combination of MGD024 with standard-of-care agents used to treat CD123-positive hematological malignancies. The Company expects to initiate a Phase 1 dose escalation study of MGD024 in patients with CD123-positive neoplasms, including acute myeloid leukemia (AML), pending IND clearance by FDA.  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%;padding-left:12.03pt">Flotetuzumab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> is the Company&#8217;s first-generation, investigational, bispecific CD123 &#215; CD3 DART molecule. An interim efficacy threshold from the single-arm study evaluating flotetuzumab in patients who were refractory to induction therapy was met with manageable safety. However, the Company has recently decided to prioritize the development of MGD024 and discontinue development of flotetuzumab, in view of the Company&#8217;s belief that MGD024 may offer certain advantages over flotetuzumab, including easier dose administration and a more facile means to combine with other agents.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Margetuximab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8239;is an Fc-engineered mAb that targets the HER2 oncoprotein, which is expressed by certain breast, gastroesophageal and other solid tumor cells. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MARGENZA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (margetuximab-cmkb) was launched in March 2021 by MacroGenics and its commercial partner, Eversana Life Science Services, LLC, for the treatment of adult patients with metastatic HER2-positive breast cancer, in combination with chemotherapy, who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease. In January 2022, Zai Lab announced that the China NMPA accepted the New Drug Application (NDA) for margetuximab for the treatment of the same HER2-positive breast cancer indication. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Zai Lab recently informed MacroGenics that they have decided to discontinue enrollment of Module B of the MAHOGANY study in gastric cancer based on their review of both the clinical data and the changing treatment landscape. MacroGenics previously announced in November 2021 that the Company had decided to discontinue enrollment of Module A of the MAHOGANY study.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Selected Partnered Program Updates&#58; </font></div><div style="padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt">IMGC936</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is an investigational ADC that targets ADAM9, a cell surface protein over-expressed in several solid tumor types, and is being developed jointly under a 50&#47;50 collaboration with ImmunoGen, Inc. Under the collaboration, ImmunoGen is leading clinical development of IMGC936 in a Phase 1 clinical trial evaluating safety and pharmacokinetics in multiple solid tumors and has indicated they anticipate disclosing initial data in 2022.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.03pt">Teplizumab </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is an investigational, anti-CD3 monoclonal antibody acquired from MacroGenics by Provention Bio, Inc. under an asset purchase agreement in 2018 for which MacroGenics is entitled to receive future milestone payments and royalties on net sales. Provention is developing teplizumab for the treatment of type 1 diabetes (T1D). On February 22, 2022, Provention announced that it had resubmitted the Biologics License Application (BLA) for teplizumab for the delay of clinical T1D in at-risk individuals. The BLA resubmission followed Provention&#8217;s Type B meeting with FDA earlier in the year.</font></div><div style="padding-left:36pt"><font><br></font></div><div id="i5d590c8f7f474939b87d9612781b16d4_4"></div><div><font><br></font></div><div style="-sec-extract:summary;margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2021</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> Financial Results</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">Cash Position</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Cash, cash equivalents and marketable securities as of December&#160;31, 2021, were $243.6 million, compared to $272.5 million as of December&#160;31, 2020.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">Revenue</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Total revenue, consisting primarily of revenue from collaborative agreements, was $77.4 million for the year ended December&#160;31, 2021, compared to total revenue of $104.9 million for the year ended December&#160;31, 2020.  Revenue for the year ended December&#160;31, 2021 included $12.3 million net sales of MARGENZA.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">R&#38;D Expenses</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Research and development expenses were $214.6 million for the year ended December&#160;31, 2021, compared to $193.2 million for the year ended December&#160;31, 2020. The increase was primarily related to development, manufacturing and clinical trial costs related to MGC018, as well as other preclinical molecules and increased clinical expenses related to enoblituzumab and lorigerlimab.  These increases were partially offset by decreased development and manufacturing costs related to retifanlimab for Incyte and decreased clinical costs and BLA support for margetuximab.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">SG&#38;A Expenses</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Selling, general and administrative expenses were $63.0 million for the year ended December&#160;31, 2021, compared to $42.7 million for the year ended December&#160;31, 2020. The increase was primarily related to the MARGENZA launch, as well as labor-related costs and legal expenses.</font></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">Net Loss</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Net loss was $202.1 million for the year ended December&#160;31, 2021</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> compared to net loss of $129.7 million for the year ended December&#160;31, 2020.</font></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:12.03pt">Shares Outstanding</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Shares outstanding as of December&#160;31, 2021 were 61,307,428.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%;padding-left:12.03pt">Cash Runway Guidance</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">MacroGenics anticipates that its cash, cash equivalents and marketable securities as of December&#160;31, 2021, plus anticipated and potential collaboration payments, and product revenues should enable it to fund its operations through 2023. Such guidance does not reflect anticipated expenditures related to the potential late-stage development of MGC018 in mCRPC or further expansion of studies currently ongoing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call Information</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MacroGenics will host a conference call today at</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4&#58;30 p.m. (ET) to discuss financial results for the year ended </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December&#160;31, 2021</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and provide a corporate update. To participate in the conference call, please dial (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and provide the Conference ID&#58; 1067087. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The listen-only webcast of the conference call can be accessed under &#34;Events &#38; Presentations&#34; in the Investor Relations section of the Company's website at http&#58;&#47;&#47;ir.macrogenics.com&#47;events.cfm. A replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MACROGENICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SELECTED CONSOLIDATED BALANCE SHEET DATA</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:138%">(Amounts in thousands)</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and marketable securities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,616&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,531&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,245&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378,743&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,646&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,382&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,618&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,884&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MACROGENICS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">(Amounts in thousands, except share and per share data)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:50.424%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from collaborative and other agreements</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,294&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,764&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,024&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue, net</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,349&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from government agreements</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,447&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,883&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,188&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product sales</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,651&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,577&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,201&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,309&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,014&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,742&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,064&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,242&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,943&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,373&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,795)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,060)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,185)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,374&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,115)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,739)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,811)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income&#58;</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on investments</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,169)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,762)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151,792)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.37)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.47)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.16)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common shares outstanding</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,944,717&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,442,389&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,082,728&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About&#8239;MacroGenics, Inc. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MacroGenics (the Company) is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics, the MacroGenics logo, MARGENZA and DART are trademarks or registered trademarks of MacroGenics, Inc. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cautionary Note on Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the Company's strategy, future operations, clinical </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">development of the Company's therapeutic candidates, expected timing of results from clinical trials, discussions with regulatory agencies, commercial prospects of or product revenues from MARGENZA, milestone or opt-in payments from the Company's collaborators, the Company's anticipated milestones and other statements containing the words &#34;subject to&#34;, &#34;believe&#34;, &#34;anticipate&#34;, &#34;plan&#34;, &#34;expect&#34;, &#34;intend&#34;, &#34;estimate&#34;, &#34;project&#34;, &#34;may&#34;, &#34;will&#34;, &#34;should&#34;, &#34;would&#34;, &#34;could&#34;, &#34;can&#34;, the negatives thereof, variations thereon and similar expressions, or by discussions of strategy constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including&#58; risks that MARGENZA revenue, expenses and costs may not be as expected, risks relating to MARGENZA&#8217;s market acceptance, competition, reimbursement and regulatory actions, the uncertainties inherent in the initiation and enrollment of future clinical trials, expectations of expanding ongoing clinical trials, availability and timing of data from ongoing clinical trials, expectations for regulatory approvals, other matters that could affect the availability or commercial potential of the Company's product candidates and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's views only as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">### </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CONTACTS&#58; </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Chris James, M.D., Vice President, Investor Relations &#38; Corporate Communications</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Jim Karrels, Senior Vice President, CFO </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1-301-251-5172 </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">info&#64;macrogenics.com </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgnx-20220224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:312ed510-66ae-416f-90ea-006795df12a1,g:01123119-117e-440f-aa80-e8f2b88ebc12-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgnx="http://macrogenics.com/20220224" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://macrogenics.com/20220224">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20220224_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20220224_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://macrogenics.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgnx-20220224_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:312ed510-66ae-416f-90ea-006795df12a1,g:01123119-117e-440f-aa80-e8f2b88ebc12-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressAddressLine1_a8e1f429-de2f-40f7-b1b8-cec0043b7368_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b6d47249-38d8-4217-a066-e59c12d32935_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cac5d2c2-e708-4f77-befd-496f965e65de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1e013a8d-2399-4a06-9a2a-2f9dd45a8ee3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1e883857-05d7-4b4a-ab7a-27ed575a618d_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3996c3e8-2c12-43ae-adcd-2a5974b77da0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_b33ca7e5-74f7-44a3-bbc5-4787e842494b_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_df6a7a60-d298-4b4d-b118-393f85efcc0b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7d0b7661-44e7-4ee4-9175-2a5be6f2ddce_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_55ecac7e-b519-498c-9de3-67b60220e18c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6ba96e8f-048f-4084-87a6-98559953d176_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3851ccc1-b952-423f-995a-4494f7edfd43_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_e714dcd5-dc42-4b33-aa77-d3b3e1fb02a2_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_c005b77e-5c79-4ea5-8f70-71a81694f051_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_89508f04-e7c4-461b-8305-146116c11a7c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_903b9081-f4f2-46df-b7d3-1c2dcc640b40_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d770b956-039a-4fcf-80d2-f17ded84ce5d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_50f4e4cd-b4cd-4e6c-8189-b4cc2eebd0c2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_53459997-9a13-4a5b-8285-904be18558dd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_53c5f007-1789-4425-b24c-600df5e9b554_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e2640666-d3a3-4ed4-bf2a-5986cfa0ed52_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_29e08710-d96b-48d5-8a47-31b648bcf4ed_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgnx-20220224_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:312ed510-66ae-416f-90ea-006795df12a1,g:01123119-117e-440f-aa80-e8f2b88ebc12-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20220224.xsd#Cover"/>
  <link:presentationLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e093644f-4d9e-413d-a934-4a6323148f55" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_DocumentType_e093644f-4d9e-413d-a934-4a6323148f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_109d7d19-4fa9-4fe4-b5c0-4c079ab99ec1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_DocumentPeriodEndDate_109d7d19-4fa9-4fe4-b5c0-4c079ab99ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ae63ab85-47b9-4697-8933-98a42ba8e8ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityRegistrantName_ae63ab85-47b9-4697-8933-98a42ba8e8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_32abc920-6da6-4f6d-b541-0e0e76660a61" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityIncorporationStateCountryCode_32abc920-6da6-4f6d-b541-0e0e76660a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_47920926-02f8-45b1-9de1-c5a6c3c858b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityFileNumber_47920926-02f8-45b1-9de1-c5a6c3c858b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_702dcf7a-da24-415a-9536-e6f444945f02" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityTaxIdentificationNumber_702dcf7a-da24-415a-9536-e6f444945f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d0cadd79-452e-4e39-bb7e-bd4833385bfe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityAddressAddressLine1_d0cadd79-452e-4e39-bb7e-bd4833385bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9e8eb36e-34d9-47aa-a09b-293a4d09ad22" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityAddressCityOrTown_9e8eb36e-34d9-47aa-a09b-293a4d09ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_46738f53-0762-4d7e-8bb1-fb670e104296" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityAddressStateOrProvince_46738f53-0762-4d7e-8bb1-fb670e104296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a0023e74-43ee-46cb-9dbe-84f3cf77661f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityAddressPostalZipCode_a0023e74-43ee-46cb-9dbe-84f3cf77661f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4ecc75b1-7cd9-4b91-a380-120c64993ddb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_CityAreaCode_4ecc75b1-7cd9-4b91-a380-120c64993ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6f600034-18da-4f3f-9857-921219cd3380" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_LocalPhoneNumber_6f600034-18da-4f3f-9857-921219cd3380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3107062a-4313-4a26-8b57-9617234a5c71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_Security12bTitle_3107062a-4313-4a26-8b57-9617234a5c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_116584cd-3da1-4068-bb67-b1463467def2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_TradingSymbol_116584cd-3da1-4068-bb67-b1463467def2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9342b407-b44b-4bab-a46e-c7c55d0d7884" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_SecurityExchangeName_9342b407-b44b-4bab-a46e-c7c55d0d7884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_34cb6cac-4204-44ef-9de8-8ae6704cc3f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_WrittenCommunications_34cb6cac-4204-44ef-9de8-8ae6704cc3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5d42e399-2454-4e50-b942-77637ae4eba7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_SolicitingMaterial_5d42e399-2454-4e50-b942-77637ae4eba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_db257c7a-de7c-4bcf-af34-bc553720f485" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_PreCommencementTenderOffer_db257c7a-de7c-4bcf-af34-bc553720f485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0e264b05-38a7-4cda-bfb3-da2d1fcbd90f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0e264b05-38a7-4cda-bfb3-da2d1fcbd90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_576f70ec-6bab-45a3-a696-b51b7ae82479" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityEmergingGrowthCompany_576f70ec-6bab-45a3-a696-b51b7ae82479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d005a4e4-8ce1-46ae-b3e1-dc83067f389f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_EntityCentralIndexKey_d005a4e4-8ce1-46ae-b3e1-dc83067f389f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_33e1ebc7-0ffb-4387-b415-d978631395d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_18beca70-e8ee-4e95-9c59-dd9f7a205c06" xlink:to="loc_dei_AmendmentFlag_33e1ebc7-0ffb-4387-b415-d978631395d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>macrogenics20logo_jpgormat.jpg
<TEXT>
begin 644 macrogenics20logo_jpgormat.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0""17AI9@  34T *@    @  8=I  0
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;>/]?\ M<YTVT;]
MQ&W[UA_&P[?0?S^E=!XYU_\ LNS^S6KXO)AU!YC7U^OI7EJJTCA5!9V.  ,D
MFF@+>D:=-JE_':VX^9CRQZ*.Y->S:78PZ;8Q6MLN(XQC/<GN363X.T(:-I^9
M0#>3#,A_N^BBN@H; ****0!1110 4444 %%%% !1110 4444 %%%% !1110
M Y''-%5Y$:([XN5[K4L4JRKE?Q'I0 ^BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110 4444 %%1O<0I*L;RQK(WW5+ $_A4E !1110
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M$'D3D#[C<K0!O45GZ3<^8GE,?F7I[BM"@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9^M0>9:[Q]Z/G\.]8$,IAF61>JG-=<RAU*MR",&N.N$,,SQMU
M4D4P.PBD$L:NOW6&13JRO#UQYENT1/,9X^AK5I %%%% !1110 4444 %%%%
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M<=L[!W!+,R]"2:TJ*SIX&A3K.O"-I-6T+EB:LZ?LI2NCC_B1_P >-G_UU/\
M*N KO_B1_P >-G_UU/\ *N KX;B'_?I>B_(^FRG_ ':/S_,[_P"'"@Z;=9 /
M[WO]!75S012H4EB1U/4,H(KD/A[<P0:?="::*,F7(#N!GBNFN-7T^WC+R7D
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MO%G4HQ4]5.#7PW$>"AAZL:E-64K_ 'H^ERC$RJTW";ORG0>!KYK36EA)_=7
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M\3M1W26^G1GA?WLGUZ ?S_,5PE4@-+PY9?VAK=G;X)5I 7_W1R?T%>U5Y_\
M#'3\R75^XX4>4A]^I_I7H%)@%%%%( HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \S\??\C"W_7-:M_#C_D)W7_7'_P!F%5/'W_(PM_US6K?PX_Y"
M=U_UQ_\ 9A7P=+_D=/\ Q/\ 4^HJ?\B[Y(]!HHHK[P^7"BBB@ HHHH ****
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MXG^I]14_Y%WR1Z#1117WA\N%%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1128&I;^!=*C(,K7$WLSX'Z 5K6GA[2;7F&P@SZNN\_KFBBD!J*JHH5 %4=
M!@"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_Q  ? 0 " @,! 0$! 0
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MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L3\Q:9S4ZA
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ME_LI_P#%._Y77^9O_4S?].5E_P!4,?\ DXW;W_*1_L,?_$+_ *$>R_\ 4O\
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MCT'\,U_:O:FG[,T\M1J)<,(_,GH .I/0?H<O1:++K,HQ8A<C]GF?(/DW7_\
MG(?S/>3R+Y?L;71[,$B)YE^L7!'8L6(0>- OTG/"^U/^"QK\TR-+"..'2QQS
M^/\ #\.'XE],T7L+I<<0<\C.7EZ8_K^WX,1;\[/S,9B1YC" FH06=G0>PK 3
MF@/_  1^WB?\8K_,Q_\ $.T'LAV6/\E_LI_\4M_Y77^9O_4S?].5E_U0P?\
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M7\YC)!K\4;.4/7N,V.#MC6X?HS3'^<:^5TX&;LC1YOKPP/\ FB_G5O8?+O\
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M^<OUN_Z&-_.K_J?+K_I'M/\ JCC_ *+>U/\ 5C\H_J7_ $*]F?ZB/G+];O\
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M.7]:<HG?W1J/P?+,>O\ SGM#&8/I$C$>Z,2/M-GXOC[/ 'U-V*HNQ_WML_\
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MSZJDA]+<@;(+AZGV%8P,!_X%7; '/&?\X_\ $J/;CL\_S_D/UL \R?E]YO\
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MD1^GO-GJ^[=E=F8NS\$<./IS/61ZD_C8;,7S2NQ=BJY59F554LS$!5 J23T
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M_P",S/\ U7>>S7_&EA_K/QJSP!]Y=BKZK_YP[_\ )M7/_; O/^3MOG;>P/\
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M?Q=?3SX#VJ]IY:<G3:8U/^*7\WRCY]YZ=-^7KJ...&-(HD6**-0L<: *J@;
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M]-*L8V,ASEWT?YOW^Y]EYZ \$[%78J\Y\_\ Y4>1OS*LVMO,^BQ3780K:ZU
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M5OR8T#]/>?=*9TY6NC<M2N?G 1Z7_)5DSN/^!YV7^?[8Q$CTXOWA_P WZ?\
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M]YWE]I+%LTCLG8J]K_(GRPFO><1J-U'ZEEY<B%V0153<,>, /R-7'NN>C?\
M R[%&N[3\:8N&$<7^?RA^F7^:\C[9]HG2Z+PXGU9#P_YO\7Z!\7W)GTJ^.NQ
M5V*NQ5V*OG__ )R$\MIJ'E>U\PQ1CZWH,ZK/(.IMK@A"#XTDX$>%3GE?_!6[
M(&H[/CJXCU8I"_ZD]OLEP^[=[?V&UYQ:HX"?3D&W]:._W7]CXPSYX?678J[%
M7Z#_ )1ZL=7_ "]\N3._.:T@:RE[D?5G,2 _[!5.?5GL'KOSG8NGD3O&/ ?\
MPF(_V(#X=[3Z;\OVCE Y$\7^F%G[;>D9U[H'8J_$_P#-F_;4OS0_,*\+<UD\
MPZBD3;_W<=P\<?6I^RHSYV[<R^)K\\O]LE\@2!]C] ]B8_#T."/]"/S(!/VO
M/<U;M'8J^QO^<+=.2?\ ,#S+J;@,=/T)HHP>S7%S#\0_V,9'TYWW_ ]Q"6LR
M3[H5\R/U/">W^4QTF.'?/[@?UOTLSU]\E=BKL5?#WYY_\Y.>9_(WGB\\G^3K
M'3FCT6.$:K?7\4DS/<31K+PC"2Q@*JNH-026KV&_G'M)[8Y]%JSI]/&/IJR0
M3N1>VXV /S?0_9SV0P:W2C/G,O5= $#8&M]CO8^3QG_H<3\VO^6;0/\ I#E_
M[*,Y_P#T?=H]T/\ 2G];O_\ 0)V?WS^8_4[_ *'$_-K_ )9M _Z0Y?\ LHQ_
MT?=H]T/]*?UK_H$[/[Y_,?J=_P!#B?FU_P LV@?](<O_ &48_P"C[M'NA_I3
M^M?] G9_?/YC]3O^AQ/S:_Y9M _Z0Y?^RC'_ $?=H]T/]*?UK_H$[/[Y_,?J
M=_T.)^;7_+-H'_2'+_V48_Z/NT>Z'^E/ZU_T"=G]\_F/U,U\C_\ .97F(:U:
M6OGW1].ET*YE$=SJ.FQ2Q7%L&V]0HTLBR*O4J #2M"309L.S?^"!F\41U4(\
M!YF(((\^9O[W7]H^P6'PB=-*7&.0D00?+D*^Y^A\4L<T<<T+K+%*H>*13565
MA4$$=01GJT2)"QR?+B"#1YK\*'8J_&O\^_\ R<7Y@_\ ;5?_ (@N?/\ [3_\
M:>?^L^\^S7_&;A_JO(<T3O'8J^^?^<'O_*G_ /;E_P"Q_/3O^!Q_R(_S/]^^
M:_\ !$_Y#_Y_^\??.>GOFCL5=BKL5=BKL5=BKX&_YSA_\IA_V^O^Q#/,/^"/
M_P A_P#/_P!X^E_\#O\ Y$?YG^_? V>8OI3L5?<WE+R(_P"87_.)\]K;QF;6
M/+>I7^J:"H%6+6[%I85IN?4C9P!_,1X9Z1H>S#VA[/&(WG"4I1^',?$7\:?.
MM;VD-![0"1VC.,8R^/(_ U\+?#.>;OHKL57([QNLD;%'0AD=30@C<$$=*8@U
MN%(O8OV6_)'\P8_S(_+O1-=DF$FKVJ#3_,*U'(7MNJAW('3U5*R#V:F?0'LY
MVJ.T=%#*3ZAZ9?UAS^?U?%\%]H>S#V?K)XP/2?5'^J?U<O@]:S>ND>1?GW_Y
M)W\P?^V4_P#Q-<T/M/\ \9F?^J[SV:_XTL/]9^-6> /O+L5?5?\ SAW_ .3:
MN?\ M@7G_)VWSMO8'_C1/]27WAXSV[_XSQ_7'W%^H^>SOCKL5>)?\Y&_^24\
M^?\ ,+;_ /47!G.^UO\ QEYO</\ =!Z'V5_XT\/O/^Y+\>L\$?='8J[%7[:?
ME3_Y*[\MO_ 6T?\ Z@H<^B>Q/\0T_P#PJ'^Y#\^]M?X_G_X9/_=%GV;1UB7Z
MMJ5MHVEZEJ]XW"TTJUFO+IO".!#(Y^Y3E6?-'#CEDERB"3[@+;<.*67)&$><
MB />33\,=;U>[U_6=6UV_?G?:S>3WMV_C)/(9&_%L^;=3GEGRRRRYR))]Y-O
MT5I\$<&*../*( 'N I*\I;G8J^BO^<8_($/GG\R[.XU& 3Z+Y4B_2M_&PJDD
MJ,%MHCXUD(<@[$*1G5^QW98UNN!F+AC'$??_  CY[^X%Y;VO[3.BT)$34\AX
M1[OXC\MO>0_6C/<GQ-V*NQ5V*NQ5V*NQ5\P_\Y=:?+>_D]<W,:\ETC5K&[F-
M*T5B]L#7M\4P%?HSC?;O$9]FDC^&43_O?]\]?[#Y1#M$ _Q1D/\ ??H?E7GB
MC[,[%6P2I#*2K*:@C8@C%7ZA?D1_SD=HOG73K#RSYQOHM)\YVR+!'<SMP@U(
M* %D1V-%E;]I"=SNO7BOLWLS[6XM9".'4$1RC:SRGYW_ #N\=>G</'O:3V4R
MZ.9S8 98CO0YP\OZO<?GWGU?G;O%NQ5V*NQ5V*NQ5V*NQ5YM^;__ )+?S1_Q
M@B_Y/QYQ_M]_QAZG^J/]U%Z#V6_XT\/O/^Y+\^<^5'W!V*HNQ_WML_\ C/'_
M ,2&7Z;^]A_6'WM>;Z)>XOU$S[4?G-BWG70!YG\JZYH?$&6]M6^J<N@GC_>0
MDGP#J*YI/:/LL=I]G9M-UE$U_6&\?]D ['LC6_DM7CS=(G?^J=I?9;\VV5D9
MD=2CH2&4BA!'4$9\@$&)H\WWX$$6%N!+8)!!!H1N",(-*_1[R%YB'FGRCH>M
M,X>XN+<1WU/^6B+]W+MVJRDCV.?7?LOVM_*G9N'47ZC&I?UX^F7VB_<7P/MK
M0?DM9DP] =OZIW'V,PS?NK>0?G=YD_0'D>\M89.-[Y@8:?  =Q&X)G:GAZ8*
M_-AG _\ !([8_(=DSA$^O-Z![C]9]W#Z??(/4^R'9_YK71D1Z<?J/O\ X?MW
M^#X/SYB?9W8J]*_*3R[_ (D\]:-!(A>TTY_TC?;5'"W(90?9I"JGYYV/L'V3
M_*/:^*)%P@?$E[H;CYRX1\7G_:?7_E-!DD/JEZ1[Y<_D++]!<^JGP]YM^;__
M )+?S1_Q@B_Y/QYQ_M]_QAZG^J/]U%Z#V6_XT\/O/^Y+\^<^5'W!V*HNQ_WM
ML_\ C/'_ ,2&7Z;^]A_6'WM>;Z)>XOU$S[4?G-V*NQ5V*OB7\_O,7Z5\X1Z/
M%)RM?+MN(BHZ?6)Z22D?['@OS&?./_!3[6_-=IC3Q/IPQK_/EZI?9PCWA]>]
MB=!X&C.4C?(;_P T;#[;/Q>%9YD]D[%7V+_SCKY?^I^7]4\PS)276;@06K'_
M 'Q;5!(^<C,#_JY] _\  E[*\'19-7(;Y)4/ZL/UR)'^:^5>W>N\340P#E 6
M??+]@'S?1#*KJR.H='!5T85!!V((.>LD"0H\GA02#8?FQYRT%O+/FG7-#((2
MPNG6VKU,#_'"?I1E.?'WM#V8>S.T,VFZ0D:_JG>/^Q(??^R=:-9I,>;K*._O
MY2^VV,YIG8.Q5]1_\XY>8^,FM^59Y-I -1L%)_:%(Y@/F.!^@Y[7_P "/M>I
M9M#(\_WD?LC/_>GX%\Y]O=!8QZD#^B?OC^G['U9GN#YJ[%4NU>]_1NDZIJ/_
M "P6D]Q_R*C9_P"&8FOU'Y;39,O\R$I?Z4$M^EQ>-FAC_G2 ^9I^8;,S,S,Q
M9F)+,34DGJ2<^,"239?H@"M@MP)=BKZ2_P"<;]*6?6_,.LNM3I]I%:Q,1L&N
M7+$CWI#3Z<]@_P"!#H1/59]01]$!$?YYO_>?:\![?:DQP8L0_BD3_I1_QY]>
MY[V^7.Q5V*NQ5V*NQ5V*NQ5\F_\ .2O^]WE+_C!>?\2BSPO_ (,/][I?ZL_O
MB^F_\#_^[S>^/Z7S%GC#Z&[%6?\ Y6?^3"\J?\QR_P#$6SJ?8G_C:TW]<?<7
M2>TG_&=F_JOT0SZR?"G8JP3SA^8OECR9:S/J%_'<:BH/U?1H'#7#O38,HKP'
M^4VWS.V<Q[0>UN@[&QDY9@Y.D(FYD^8_A'G+;WG9W/978.J[1F!")$>LC](_
M7[@^!_,FOWWFC6]0UW46!NM0DYE%^RB !4C7V50 ,^7NV.U<W:FKR:K-]4S?
MD!R 'D!0?:^S]#CT6".''RB/GWGXG=(\UCF.Q5]!?\X^>69-0\S7/F26/_0]
M!A9()#T-S<*4 'CQC+$^%5SU7_@4]C2U&OEK)#T8@0#_ $YBOLCQ7W7%X?VY
M[0&+2C3@^K(=_P"K'?[Z^U]FY]#/D['_ #9?G2_*_F/45/%[+3+J:(_Y:1,5
M'TFF:KMS5'2]GY\PYQQS(]XB:^USNS,/C:K%C_G3B/M#\T,^.7Z"=BKL5?9G
M_..FG"W\IZMJ16DFHZD8PU.L<$:!=_\ 6=L^AO\ @2:3P^SLN;K/)7PB!7VF
M3Y/[>9^+5PQ](P^V1/Z 'T'GJKP[L5=BKL5=BK%//=@-3\F>:+(KR:73+DQ#
M_BQ(RZ?\,HS1^TVE_,]EZG'WXY5[P"1]H#L^QLW@ZW#/NG'Y$T?L?FWGR ^^
MNQ5V*OM'_G'6Z:7R9J5LQ)^J:M+Z?@%>&%J#Z:G/HG_@2YC/LO) _P .4_(Q
MB?OM\E]N\8CK82[X#["?V/?L]2>)=BK\,O.<SW/G#S7<2 ![C6;Z1PO0%[AR
M:5KXY\V]H2XM3E)ZSE]Y?HK01X=-C Z0C]P8UF(Y;L5?='_.$7#]+_F#6G/Z
MGI_'QIZD]:?AGI/_  .?[S/[H_>7SK_@A?W>#WR^X/T*SU1\O=BKL5?C#^>$
MLDWYN_F&\HXL-;N4 I3X4;@I^E0,^?/:.1/:6>_YY??/9T =G8*_F!Y7FE=R
M[%78J[%78J[%7[;_ )6R23?EE^74TKF267RQI#R.>K,UE$23\SGT5V*2=!@)
MY^'#_<A^?.V !KLX'^J3_P!T6=YLW6NQ5^-?Y]_^3B_,'_MJO_Q!<^?_ &G_
M .-//_6?>?9K_C-P_P!5Y#FB=X[%7T9^0'YV:7^3O^+?TEHEUK/^(OJ'H_5I
M$C]/ZG]8Y<N?7EZXI3PSK/9?VBQ]D>+QP,N/AY$;</%_Q3ROM-[/Y.UO#X)B
M/!Q<[WXN']3Z,_Z'9\K?]21JO_21!_3.L_Y.+I_]1E\P\K_R;[/_ *K'Y%W_
M $.SY6_ZDC5?^DB#^F/_ "<73_ZC+YA?^3?9_P#58_(N_P"AV?*W_4D:K_TD
M0?TQ_P"3BZ?_ %&7S"_\F^S_ .JQ^13/1_\ G,WR7J&J6%C?^6=3TFTO)DAF
MU)I(94@#GCZCJ"IXJ35J;TZ ],NT_P#P0=+DR1C+'*()J[!KS]W>U9_8+4X\
M9E')&1 NJ(OR][['SOW@W8J[%7P-_P YP_\ E,/^WU_V(9YA_P $?_D/_G_[
MQ]+_ .!W_P B/\S_ '[X&SS%]*=BK]2_^</I7D_*-T<U6#7+V.(4Z*4A?];'
M/:/8*1/9WNG+]#XY[=1 [1]\(_I?#WY_^0#^7GYEZUIUM (=&U<_I700H 46
M]RS%HP!L/2D#H!X 'OGG'M1V7_)^NG "H2]4?<>GP-CW/H?LSVG^?T4)$^N/
MIE[QU^(H^]XKG//0.Q5]4_\ .)WYB+Y2\^MY8U"?T]'\[!+5"QHL=_&2;9O^
M>G)H]NI9?#.U]A^UORFK\&9]&7;W2'T_/E\0\9[:]E_FM)XT1ZL>_P#F_P 7
MRY_ OU)SVA\=>1?GW_Y)W\P?^V4__$US0^T__&9G_JN\]FO^-+#_ %GXU9X
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M_)^/./\ ;[_C#U/]4?[J+T'LM_QIX?>?]R7Y\Y\J/N#L51=C_O;9_P#&>/\
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M@\C$_<VZ<D9(D=X^]^7N?%C]%NQ5V*OKW_G&W_CB>9?^8Z'_ )-9[W_P(/\
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M]1_^<.__ "4MS_VW[S_DU;Y[/[ _\9Q_KR^X/COMW_QH#^H/O*M_SEA^7O\
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M\GX\X_V^_P",/4_U1_NHO0>RW_&GA]Y_W)?GSGRH^X.Q5%V/^]MG_P 9X_\
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M?GSGRH^X.Q5%V/\ O;9_\9X_^)#+]-_>P_K#[VO-]$O<7ZB9]J/SF[%78J\
M_P"<A/,?Z-\K6F@0R<;GS!<5G4=?JUL0[=.E7*#W%<\L_P""MVO^6[/CI8GU
M9I;_ -2%$_.7#[Q;VWL-H/&U<LY&V,;?UI;?=?V/B_/G=]:=BKU7\F/+_P"G
MO/NE&1.=KHP;4KFO3]P1Z7_)5E^C.X_X'G97Y_MC'8N./]X?\WZ?]F8O->UF
MN_*]GSKG/T#X\_\ 8V^^L^HWQ1V*O-_S9\O_ .(O(FMVR)SNK"/](67<\[:K
ML /%DY*/GG(>W797\H]D9H 7* XX^^&Y^<>(?%W_ +,Z[\IK\<CRD>$^Z6WV
M&C\'Y\9\ION+L5=BK[__ ">\Q_XC\BZ4\DG.\TD'3KRIJ:P ",GYQE3\\^I_
M8#M?^4>R,1)N>/\ =R_S>7SCP_%\1]J=!^4U\P!Z9^H?YW/_ &5O4,[1YUAG
MYBJS>0_-X52Q&DW1H!781DD_0,Y[VM!/9&JK_4I_<7;=@FM?@_KQ^]^<>?(K
M[T[%78J^OO\ G&V?EH7F2VJ*PW\4M._[R+C_ ,:9[Y_P(,MZ340[I@_.-?[U
M\M]OX5GQ2[XD?(_M?2.>OO NQ5V*NQ5V*NQ5V*NQ5\F_\Y*_[W>4O^,%Y_Q*
M+/"_^##_ 'NE_JS^^+Z;_P #_P#N\WOC^E\Q9XP^ANQ5V*NQ5V*NQ5V*O4/R
MTT/R%KFI1VOF[6KFQN'D"VECQ6&WF/96N>3$$]*<5]FKG:^QW9O8^NSB&OS2
MC(G:-",)>1R6:ONJ/E*WG?:#6=H:;$9:7&)"MSSD/\S]-R\P^[-(T;2M!LHM
M.T>PATZRB^Q!"M!4]68]6)[DFN?36@[/T^@Q##IX"$!T'Z>\^9W?&=5J\NJF
M<F61E(]2F>9CCNQ5YU^;41E_+KS4JD BU5]_!)48_JSDO;N''V)J1_1!^4@7
M?>S$N'M+"?/[P0_/7/E%]R=BKL5?>'Y%R^I^7&DIS+>A<7:%37X:SN]!_P %
M7/IW_@9SXNP\0OE*8]WJ)_2^,>V4:[2F>\1^X!Z_G?/+.Q5V*NQ5V*H#5)5A
MTS49G^Q%:S.]/!4).8VMF(8,DCR$2?L+=IHF66('4C[WY?Y\6OT4[%78J^PO
M^<;XF'EWS#/^S)J*QCYI"I/_ !(9[_\ \"'&1HL\N_(!\HC];Y9[?2_PG%'^
MA]Y/ZGT;GKCP3L5?CQ_SD3I#:-^<OGF K1+N\2_B;>C"\ACG)%?\IR/HSP/V
MKP>#VGF'>>+_ $P!_2^Z^RV?QNS<)[A7^E)'Z'BF<\] [%7MG_./'F:/RM^;
MWE"\N)!'::C<-I5VQ-!2^0PQDGL!*R$U\,Z'V4U@TO:6*1Y$\)_SMA]M//\
MM3I#J>SLL1S XA_F[G[+?L-GOCX4[%78J[%78J[%7@?_ #D__P"2,\\?]NS_
M +J=IG,>V7_&3F_S?]W%Z7V/_P"-7#_G?[B3\B<\)?<'8J[%7[:?E3_Y*[\M
MO_ 6T?\ Z@H<^B>Q/\0T_P#PJ'^Y#\^]M?X_G_X9/_=%GV;1UCL5?C7^??\
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MLD\HZ)%YD\RZ/H4\[VT6IW ADG0 LH()J =NV;?L'LV/:6OQ::4C$3E5CF'
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M/]27WAXSV[_XSQ_7'W%^H^>SOCKL5>)?\Y&_^24\^?\ ,+;_ /47!G.^UO\
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M'TO_ ('?_(C_ #/]^^!L\Q?2G8J_4?\ YP[_ /)2W/\ VW[S_DU;Y[/[ _\
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M$1$>Z(I^?-1GEGRRR2YR))^)M'9DM+L5>;?F_P#^2W\T?\8(O^3\><?[??\
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M?.&<D]6[%78J^_OR _YR<L8K&Q\E?F7?_5)+14M]$\US']TT2CBD5X_[+**
M2'8C[9!')O4/9?VQ@(#3ZR55M&9Y5W2_XKY]Y\S]IO9"9F=1I(W>\H#G??'_
M (GY=P]W6]Q;W<$5U:SQW-M<()(+B)@Z.C"H964D$$=QGI<)B8$HFP>H?.)1
M,21(40K9)B[%6!>=_P S?(_Y=VC7/FK7[>PE*<[?3%;U;R;K3T[=*N02*<B
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M4R_YO^XB]4SMWFWR;_SDK_O=Y2_XP7G_ !*+/"_^##_>Z7^K/[XOIO\ P/\
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MQV*OQK_/O_R<7Y@_]M5_^(+GS_[3_P#&GG_K/O/LU_QFX?ZKR'-$[QV*L_\
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MO3D_N.(=\91/V7Q?,/KF#VL[-RC^\X3W$$?HK[4L_P"56?F%_P!2I??\"O\
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MP0Y>BU^?1S\3#(Q/EU]XY'XOF_S+_P XYR!I+CRGK*LIJ5TW4=B.]%GC!KX
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M/^QM[%Y<_P"<<KJ1HYO-6M);Q=6L-.'.0^QFD4*I^2M\\] [(_X$>21$M=F
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MU'_90_XI?]&'97^K?[&?_$N_Z%@_//\ ZD?_ +F>F?\ 97C_ *#>UO\ 4?\
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M%C+]&($=21MO05I7/6O9;LK+V;HABRUQ&1EMTNMK^#Y3[3]J8NT=8<N*^$1
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M&AJKR@_Z1*/]9QQ![A0<LB$/%L*NQ56M[>:[N(+6VB:>XN9%BMX4%6=W(55
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M[%78J[%78J[%78J[%7YW_FG_ .3"\U_\QS?\17/DWVV_XVM3_7/W!]U]F_\
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M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J_._\T__ "87FO\
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ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK\[_ ,T__)A>:_\
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MWE(J].OP*0?YADA%7R?YQ_-#SEYX9H]9U1H]/)JFCVE8;4;U%4!)>G8N6.2
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8BKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140241018135672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 24,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MACROGENICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1591613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9704 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-5172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGNX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001125345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>mgnx-20220224_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgnx-20220224.xsd" xlink:type="simple"/>
    <context id="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125345</identifier>
        </entity>
        <period>
            <startDate>2022-02-24</startDate>
            <endDate>2022-02-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF80L2ZyYWc6OTY0Zjg3MmE2ZjQxNDU4NWE1MmRjYzVjM2M1NDg1MDUvdGFibGU6OWQ3ZTBlMTEzYTg2NGVkZGE1YWIwZDk4ZTYzNTNjMjQvdGFibGVyYW5nZTo5ZDdlMGUxMTNhODY0ZWRkYTVhYjBkOThlNjM1M2MyNF8yLTEtMS0xLTE3ODY3_2fb93857-3d17-4dc1-8982-93cb5491272f">0001125345</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF80L2ZyYWc6OTY0Zjg3MmE2ZjQxNDU4NWE1MmRjYzVjM2M1NDg1MDUvdGFibGU6OWQ3ZTBlMTEzYTg2NGVkZGE1YWIwZDk4ZTYzNTNjMjQvdGFibGVyYW5nZTo5ZDdlMGUxMTNhODY0ZWRkYTVhYjBkOThlNjM1M2MyNF8zLTEtMS0xLTE3ODY3_d39e0811-40c7-42d0-8d53-759f3f61eeb0">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xMDY_0742c4da-8bbf-4f9f-8591-348208c39ef3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8yNTI_c64596b8-8480-4897-b459-fc6af6d27962">2022-02-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8yNTc_ed898f18-43e1-438e-bcbd-138868efcd4e">MACROGENICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTAtMS0xLTE3ODY3_92e56f87-5ebb-4a13-a937-0bf69d22e8e8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTEtMS0xLTE3ODY3_04ef72d8-cb3b-459e-9267-f756ec853ed1">001-36112</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6YjE2NjMzZWMzM2E4NDQ3ZGI5MzQxZDRlM2M0N2Y2NmMvdGFibGVyYW5nZTpiMTY2MzNlYzMzYTg0NDdkYjkzNDFkNGUzYzQ3ZjY2Y18wLTItMS0xLTE3ODY3_100b7ffe-8dfa-4a53-9f08-a807de025932">06-1591613</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8wLTAtMS0yLTE3ODY3_6569468f-6fe3-49ca-91a6-de49ea1b0942">9704 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTAtMS0xLTE3ODY3_69cf3da9-2b91-4ae6-bd09-75f295b69fb4">Rockville,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTEtMS0xLTE3ODY3_76e234c7-d143-43ce-bf79-a2877fbbb25d">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6NTE4ZDU3NDAyNjcwNDI4YmI1OTU1MjYxNDJjMjdkMTIvdGFibGVyYW5nZTo1MThkNTc0MDI2NzA0MjhiYjU5NTUyNjE0MmMyN2QxMl8xLTMtMS0xLTE3ODY3_a25cddf8-6e94-47b6-a5dc-a1f9864a2723">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8zNzM_489496a0-0015-46a4-9f7b-16935a6c1475">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8zNzc_66e58a17-08ea-4d50-ab14-536166fb70e2">251-5172</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTAtMS0xLTE3ODY3_deced0b7-3e7f-4925-b122-770fd41353ba">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTEtMS0xLTE3ODY3_86dbd62c-5e10-4e5e-8712-9453a88cc32a">MGNX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGFibGU6MTk5YWZhMGMxZjQ2NGI1MDgwY2NkZGNjOWM2OGFmNTcvdGFibGVyYW5nZToxOTlhZmEwYzFmNDY0YjUwODBjY2RkY2M5YzY4YWY1N18zLTItMS0xLTE3ODY3_0264b100-390b-4b54-a3d0-17cedcf98321">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQy_85ee0616-207a-4172-914a-a5b64de91679">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQz_261ba07e-65c0-419a-814c-90c2efec67e4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ0_9eecf223-6f34-49d0-bb5d-73444b02b683">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ1_1690f839-b3b6-4be8-b0c8-2ce4a64775f6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ3NGY0NTNmMzA1ZTQ0Y2I5ZWJiNDE3MjJmZDkyZjk0L3NlYzo0NzRmNDUzZjMwNWU0NGNiOWViYjQxNzIyZmQ5MmY5NF8xL2ZyYWc6YjAwZDhhYTA1YTk0NGFlM2JkMGNiNTYzZDliMWEwNjUvdGV4dHJlZ2lvbjpiMDBkOGFhMDVhOTQ0YWUzYmQwY2I1NjNkOWIxYTA2NV8xNjQ2_55b17fcc-d3c4-4219-8c86-98acc3a97319">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .6 6%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #E@%A4S?2NSNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2@,Q$(=?17+?G4TJ"F&;B^*I!<&"XBTDTS:X^4,RLMNW=W=MMX@^@,?,_/+-
M-S"M2=+$C,\Y)LSDL-P,O@M%FK1F1Z(D 8HYHM>E'A-A;.YC]IK&9SY TN9#
M'Q!$T]R!1])6DX8)6*6%R%1KC309-<5\QENSX--G[F:8-8 =>@Q4@-<<F)HF
MIM/0M7 %3##"[,MW >U"G*M_8N<.L'-R*&Y)]7U?]ZLY-^[ X6V[>9G7K5PH
MI(/!\5=QDDX)U^PR^77U\+A[8DHT0E2-J,3M3G#9W$O.WR?7'WY781^MV[M_
M;'P15"W\N@OU!5!+ P04    " #E@%A4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .6 6%2NK+_@, 0  #00   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9A=<^(V%(:OM[]"P_2BG2&Q93Z2[!!F")"4V870D'8[[?1"V (TL257DD/R
M[WMDP&9GS3&YB2W;Y^71.=(K*;VMTB]FP[DE;TDLS6UC8VWZV?-,N.$),Y<J
MY1+>K)1.F(6F7GLFU9Q%>5 2>X'O=[V$"=GH]_)G<]WOJ<S&0O*Y)B9+$J;?
M[WBLMK<-VC@\>!+KC74/O'XO96N^X/:/=*ZAY14JD4BX-$))HOGJMC&@G^^"
MM@O(O_A3\*TYNB>N*TNE7EQC$MTV?$?$8QY:)\'@\LJ'/(Z=$G#\MQ=M%+_I
M H_O#^KW>>>A,TMF^%#%WT1D-[>-ZP:)^(IEL7U2V]_XOD,=IQ>JV.1_R7;W
M;;O=(&%FK$KVP4"0"+F[LK=](HX#_!,!P3X@R+EW/Y13CIAE_9Y66Z+=UZ#F
M;O*NYM$ )Z2KRL)J>"L@SO:'ZI7KGF=!RCWPPGW8W2XL.!%VSY>7)&@W2> '
MP??A'A 4&$&!$>1Z+0R#_#-8&JNA4/\BDJU"LI5+MD](CE28P?"QY/D]Y54]
MQ,.O+[X@$.T"HGT>Q)QKH2(REA&!.E7RX$J'C/_TZ5--SCL%6P=5'$LK[#MY
MXFOAL@Z0,Y94DN$ZT\'PZ?%A/)L,%TTRF0TO$;9NP=8]AVTB0Z53I9F;P4VR
ML) ZHC09JDQ:_0[7J!(8%Q^-$<*K@O#J',)[$7,RRY)E]2S"-7R?7K2ZE&+5
MO"YXKL_A>69O9!+!B!,K$>9I0^AP1;][03LWM$M;"-Y-@7=S#MX@BC0WIGFX
M(5_A._(H*ZN(*]Y<^6TRY1%T,R9#Z#$8R$B#Q2.TU"]MT?\0[]"U8.0]JZVL
MM$M<[DF%+Z\BCGD3HSLR;?HANF)BS+5Z%3*L3&>-YG2$H95&3H,/H<V5L5"@
MOT5Z<K;6* ;^=<?'V,H5@>*>GA=Q )N7TRBX0,NG&$BY*E#<S+\J-VCG&R4Q
M\Z@1"3KTHD.O,/.@Y5I <1-_%A:,3*T(#7Y9_DH6/,PT9*L2"U<:JB0!UUE8
M&/)-DC)-7EF<<?*S?^E3DL(L-1NFT5E:KA(4=_)GS2(AUV3QGBQ57 F+"TP?
M9G]A).5J0'$K/R2,C-_"#9-K?G(QK1&:#1:CP>\84[DB4-S OP&0Y9*XBF1R
MOQR82B9<:,5B@Q:L7 4H;MH+%8M06%>S*5B6%JRZ:KA*'4]0VGR ^_)<\XL0
MTL/!,W>;12XC&**/JU7UG*S1JR4K+3[ [?@'LHDQ&9#5 N*RM8!'._:SC'Z<
M<+UV]7P !;MQ@RUELM(X:@1KT4J?#W";WJ.Y38$&GYU QM[(%UX-A4OYL$>C
M0:?5[F!DI?$'N&</H)117L[[F*TK>7"!DTGRCLZ [CP]9:XLAL1\!4+^Y16X
MMMX=47<-J]+\6+A4%@Z9^>T&CO5<NP_@_4HI>VBXDV;QCX+^_U!+ P04
M" #E@%A4GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"
M/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[
M1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK
M6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)
ML;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP
M::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2
MVSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=
M5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>6
M5Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEU
MXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z
M6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//
M\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#
M$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_N
MG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=
MXI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%
M^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_
M5U/\!%!+ P04    " #E@%A4EXJ[',     3 @  "P   %]R96QS+RYR96QS
MG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2
MW!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N
M&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HC
ME5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,E
MC'%BM/XU@LD/['X 4$L#!!0    ( .6 6%2JQ"(6,P$  "("   /    >&PO
M=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'
MA8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>
MBD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#
M.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'
MV#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T
M/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G60VY6= ;N\N@#FW+()FKJ
MIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ
M_)[E#U!+ P04    " #E@%A4)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N
M"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7
MK.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*
M%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)
MKM\,<'AT_@%02P,$%     @ Y8!85&60>9(9 0  SP,  !,   !;0V]N=&5N
M=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2
MVS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\
MFK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9
MHS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM
M0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-
M"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&
M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #E@%A4!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( .6 6%3-]*[.[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .6 6%297)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MY8!85*ZLO^ P!   -!   !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .6 6%2?H!OPL0(  .(,   -
M          "  7,,  !X;"]S='EL97,N>&UL4$L! A0#%     @ Y8!85)>*
MNQS     $P(   L              ( !3P\  %]R96QS+RYR96QS4$L! A0#
M%     @ Y8!85*K$(A8S 0  (@(   \              ( !.!   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( .6 6%0D'INBK0   /@!   :
M      "  9@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( .6 6%1ED'F2&0$  ,\#   3              "  7T2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ,<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mgnx-20220224.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://macrogenics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mgnx-20220224.htm">mgnx-20220224.htm</File>
    <File>exhibit99-1earningspressre.htm</File>
    <File>mgnx-20220224.xsd</File>
    <File>mgnx-20220224_lab.xml</File>
    <File>mgnx-20220224_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mgnx-20220224.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "mgnx-20220224.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgnx-20220224_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgnx-20220224_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mgnx-20220224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgnx",
   "nsuri": "http://macrogenics.com/20220224",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20220224.htm",
      "contextRef": "i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://macrogenics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20220224.htm",
      "contextRef": "i26e357beeb2c4369823bf90e695ff8ff_D20220224-20220224",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001125345-22-000014-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001125345-22-000014-xbrl.zip
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M/FG]+Q$)Q.?B_W8MQEE7JG# P6MT1)ID ACR8 04=E)4J&#YC'9$4475"4^
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M07-J4#DO)/,1\KDVXCAT0<1W8. L_YY5>"<)M5!;<R2Z"'C7$P4>4R&6:--
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MLOR*Q3J@!@ TSL[ GV/7X)F@G;\6T9UT!/@+9UA>FWMVCKNIERP^SH)<.?%
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M"K"1(^9*+/3$T^[=!&;\VEP-.M-ZFYT&UI=.@07*KAV8'+>$Y_3IR?RI2G.
M>;$^F;4KRQ98EQGV)FOBCZ\M+\3::]4G<J^G:.,M8Z?4Y<;SZ?3U?/7$P_=Y
MT.FW 41 =-%6\2T<V7LW5N)6KI5G77SER$[GIG!5_/9=$#] Y\*]3+G7;NC3
ME1#Q*YTI,_U)XYL;"JQJF9<$8('>8SN'C<8NJU5JI8/J?HWMN,K'%@=G%RW
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M ?I$R(")H ^[!OH#LO&2"I"P6  L\)3GJ:'&[AAGB1JC#6?P98SCYN"+[KQ
M.0,*PJ!8W-$U2W2YDNC##IS):V-5$+.A3 :L[ZDN/#3%-#@5L%)N)YJ-I(#]
M?P9J^RK";D'<&\UFP58%H!M6%7GH?X5E1#=&2O&$#8?#LH^HZA.JRC!IF17$
M#X?F61S65A8[;UU]Z5S\LT5PG;2N;ABX?L!MW!7 (;?@!$8L@BW&L'G$7NZ'
M'EM3\9ZOE]H\170B?U\H9.\ T3WDD5LZ4^H6*7^= #F+G6>K@741'E]+%;9
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MF3-P,WF:(7XF,FA%,_<^U(M]/8<U^):[O,W"$5X,(SWX!H]@S;X8ACTVPS.
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M]WU1:!>=<@\=BD +?65IA@[RDNF[E]ZM3()?1X;#W.%I$D\B#Y=X\?.?C\_
M@41=+,]/<JO($]C^>-FS!W3#F3]U("KXZR]6Y:=+^KVJ_)2J9*Y7-W>GI+Y2
M557S\;/O1E52USN"*'WR>8>2OG+NBE[W0LVU\HD_G>;Q,IB/E^Q<*4<E/^;'
M!C =2N,P\-!<KLI6\+&7-#Y*,4T0B=,TH'2QEY>(T3OB(HGB61"WC]R0I>G:
M.>IGQNMK2V]T$I;' 8>SD1.'&VL%@P]#67&4]9MRZKP2/F=4/G]:#&S/>3^
M;ZX,U-UKAGY&E=($K43\[Z% EB<"GC#$*=V/&:%.KJ;>9(A3I/:LSE#M'O?Z
MUIXU[0WVJ;W7(E;C%$(;>]C;LP?M8XM"Z#.R.^[-U-ZTW0G[O5'SO'L![8VN
MU!T<G;<;?PRZ]&#8I9;:O>@JW>,NL8FX3.3&J8S'7>Y)CHYEKOM8,:F*'4(I
MUG7)]Q0BJ[+#*ENBX @DZ3"+W>$F&K,$G;%PPM'_2E6)H+&X4J/_D$KJ5R9@
MKRV9]H0R5!JIPD:]"] : G3C[,?0/,?3J(M53B2L<)5C0R<4FXHJ,\-P79F"
M  'H?]WCW.=IY>(W<1=>S"[-'UDO'LZ\>>XJ7)0W?^3Z?&)WHW!<HIKB "6Q
M;$H.5AQ5P4SV)$QTL&>N;QHR)<(G3#WV-]H+8X>%Z)"'W,V0Q9(AS]:M)+]U
M6/$6TX"EO,G:I;BM<]AR>]1S[VVGS]UAGC-BXW$2CY- E+<[\10Y/(S/1=)-
M-(I<'#+PG\@/0A%Q!2D*Q&V)'O=$$BH-1I,P8Q&/)VDX0RG+@M2?Y2/+ ;$#
M="PJ5LL<57+U/"UH7W!P6#2;M_EQ"(N+<:)L(A!UV"G:2#E'>SSB"7!:*X*Q
MDR+UM5VEU0+<#_65^"YS64+ETKE2?7GT/Z&./ 8%"102CN4D*JN%T]M*THGC
M$$0WC#,@^IO4D_>_%<@>[,].#)5S22,:(%%G6%S5ADVB,,Q41U,\;A)--X4.
M,'5%^7A3IZ$2RT"YZVA>R- >3.9)>86J):\+)K^6VQ4WKFP0'>WL'B J2U7H
MN#JC_=MQ\B&X1RX@*CJU0#F!A@K?V?@&&U^<4(TX3-(YUE07O&1B,FP0Q<6F
MY%+N<U?3N;*:C:]0C$8ECE?PL! -0J^Q\<*U09=,K$C5HN<['U_R\;>$"VTL
M+N;,KV$3YC-I^[XX.G[GYP5^EDY,SEV?4AEKOJQ@Q03/TW%4#^NRHBB.1!W-
MD%?S,Z :N]=PO9Y^)HJ'\V.TM;B[Z/O.WZOXNY6F$YZ\<_EJ+B<G1#,EWY!-
M[,B.!D$6-[ CN0:F+E>8INBZZFN/SN4RQ\J&NQZ7EWUO<_E:0<[M ^1K0J'>
M$ IQV>$+"44K$@^.B,!GAMP\(@(XA^B\S_.'?&^$*Q#\ (B <;&54W2:Q.=9
M7^!^+$(8EB*/^[!$?C600#M2)'4>V=QP^HIK]F2T(4BC?\Q]OWEG6 :H,A87
M"XERB'PF0AU,E\RU[.Z^RTD%':_&79NVBNY-N1<B5',%TI^RSJNH=)ZOO)<O
MO%.L^Z[1;F@T>J*J#M%]U\6>[(+=IL3$AFMHV#28Z\K,U&6R.IQZ^XK$_X%J
M$*6K2_5,<"LCT@<MDN?20(M$<:[ )RG/>\%&R[R+> -&D&= BFO+!3/F:X4S
ML7C^&A8A'!'L#5H2?A:D, YT$XM<X>$#1<0]2:*S>$.)QQ(O+3(NWJHJ(WF#
M758975<Z5830)5%7$/'Z!>?CN "]GO"0B8+N6U>>7Y4LY327KH8P)XW#279[
MR,]N2;_K5>WZY57M_<NZFS$[Y=A).!MBYH,2K;/PG,W22NVI[G,7:@4#T1/F
M9O5T,@*.F57>3ED74:LR??RGGPU:5?3U[H1[HEO67J8&HY7Q$:)5B3[YI4,O
ML[\#GD["+'_JHPU:K71D03>AW4NUM1.#&KU]X<I#'W]8% OSQ6Q(.T++;Y'=
M1,AB;A+O<7#QTTUQ<TL5;0A-7)G[(Q\ 51'H='=1SP/ZX@*;H.J3$L4LQ[)H
M$W9#3",N]T6%<6EP""D<GA00R"2'@%111V3G)V&(\A>(E(9@G#^H YJ<,S!2
M@8C[<N<7O+"H-!RY,<J/&4KX\GA%>-)9QL 4>@*<YK0?.$&&0-L0875R9W5G
MDB2B;U'H*\J-YH<1U9]4[SX7P01.@NCR7517%G0>8,$N+@]0-JX>7[F^W0^B
MO@/0*HR]PR&"  1YJ.('(?=R+U.88[" /"?:I3DVUHX%<C:YWE3)HXI8!#CG
MX!>@=.(,Q.%=CG>.PH Y05C,F*_!,I06RVX"E$D);W =W.#R*B'X "[.Y7MH
M!#,(3Z0\#%J9 R_#H4W!#&R4<^(FBF_'J)NB_(R/\YM8^31G/W'LQ#.!*6 T
M6#LM+FAU%X%()R[X1"4<J_CG'H])/;LUIIIY3VM<.B&/;8WU-:?]]:RQ614/
M'OV2UOC*YN8/N0N=71CC4G4MJU2^^YG^&W)E%>WQ[R$&X9'E!USD\^O=+RG>
MGS'GL.J=1>OV@PFOFQO?5?G+WQ4R=\6*)SE_L8M0&CQUDV \+[XI]_KS>P,>
MY5K E5OV_2>K/2S@\[A;WFI9SQU.T0M@8DL3*[Q RL<7!Q 5[WHLX3%-3" H
MBP#Y:>[F)KS:SP"U(F;X5&./4 #^3MO71MMO>3A]4(;37AY-Y;3^-;:W^POM
MA?]">RE23NCJG45+M<N;-/K+"]2)I#SD"8&WM-6=&*!!W]@I1RWAYP)_BDMT
M&BQC:$,D^CR1KQ))NB#*LRVMW*]%XE7KR"O?%/;@BV;ND8:5%X_ZY-=Q@6CQ
MZKS6GKW=.3IH/G K=RX=O^^TSYT7O?Z*Q.)\\^])D)19A/7REIO+#D:]23A#
M+IN(P\P\N5J^50^6<2!R \: !O!U(7J$+_HL]$5"4$R4Z\2R0Y\G?!+!F'PZ
M-LGZ<0*;\VYG!=\:WE_T+4]&E2KJ?>)9Q:AJ3_ Z)J5*5?WQ9Q6OI+K3]0^_
MM'D1KXZL7YY:77,A5EC7>]\]_6SYT.7[7/*>N_LZ2 ^[C.X5XN:/6?VILN!K
MQ9Q/N+D?Q9RUM(:^<-]/^ Q]X^"-I"]_*IG3XU4"=<BC($[0]\#EHGHU#82M
MS$\4Y@]VB3>WI3Q\K%<:K.%.O9*RI)H3>S/X!;%8N/7_4$L#!!0    ( .6
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MA@';WAD'J%NR[XGT9M2!@6Y):AOGMH:]]_.O;R^7$)*(4@V(I!Q@+0A@,86
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M1^KN#\LT!1WN<9D=*=4>F-G5SAU@Y$>723'34^V'&(9A"%0@S/2M%091[ M
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M_J-_T?Y@Y[]02P$"% ,4    " #E@%A42%LX%0$D  "!)@$ '@
M    @ $     97AH:6)I=#DY+3%E87)N:6YG<W!R97-S<F4N:'1M4$L! A0#
M%     @ Y8!85*]AU]S6%   <XL  !$              ( !/20  &UG;G@M
M,C R,C R,C0N:'1M4$L! A0#%     @ Y8!85/30F&YN @  <0<  !$
M         ( !0CD  &UG;G@M,C R,C R,C0N>'-D4$L! A0#%     @ Y8!8
M5&*L:21 "@  =%T  !4              ( !WSL  &UG;G@M,C R,C R,C1?
M;&%B+GAM;%!+ 0(4 Q0    ( .6 6%3QM>](K@8  #8Q   5
M  "  5)&  !M9VYX+3(P,C(P,C(T7W!R92YX;6Q02P4&      4 !0!0 0
&,TT

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
